The FC2 Female Condom is a contraceptive product that provides dual protection against sexually transmitted diseases and unintended pregnancy. The company holds worldwide rights to the FC2 Female Condom, including patents in various countries. The product is available in the United States and approximately 138 other countries. The Female Health Company is committed to improving women's reproductive health and increasing access to contraceptives and HIV/AIDS prevention.
Commitments made to:
In 2012, Female Health Company committed to providing US$1.65 million in savings per year for eight years based on a bonus of 5 percent of 60 million current public sector volume units worldwide (US$1.13 million in savings per year for eight years, 5 percent of estimated 41 million units annually in Sub-Saharan Africa and South Asia) in “no cost? product.
Female Health Company Commitment Narratives
Become a FP2030 Partner